Most active investors · Last 90 days
Ranked by rounds participated in, from announcements in Jul 21, 2026 – Oct 18, 2026. Lead counts include only confirmed lead roles.
Browse by month
Details
New companies 2 · Follow-on 0
Stages: Seed 1, Series C+ 1
Nat Habit ₹1.4B Series CProtein Pantry ₹90M SeedDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Ocean, Inc. Undisclosed Series A second closeJIJ $5.2M StrategicDetails
New companies 2 · Follow-on 0
Stages: Series A 2
THE PHAGE ¥570M Series A first closeCORE Biomedicine $21M Series ADetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Osavul €8.5M Series AExein $270M UndisclosedDetails
Details
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Arena $200M Series BHorizon3 $250M Series EDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Arena $200M Series BRiver AI $1.1B Seed and Series ADetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Osavul €8.5M Series AINLEAP Photonics ~€20M SeedDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Vesta $30M Series BSkan AI $63M Series CDetails
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Series B 1
Stuut $52.5M Series BLimetax €36M Pre-seed equity and acquisition facilityDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Vinci $250M Series BDevoted Health $555M Series GDetails
New companies 2 · Follow-on 0
Stages: Series A 2
Flyle ¥1.9B Series ABridgeSmile Co., Ltd. ¥819M Series ADetails
New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Every WiLL Undisclosed SeedTokoshie, Inc. Undisclosed FundingDetails
Details
New companies 2 · Follow-on 0
Stages: Pre-seed 1, Series B 1
indent ¥1.1B Series B final close, completed April 2026Pop Mint ¥50M Pre-seedDetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
MOLCURE Undisclosed Strategic investment agreementUnited Immunity ¥2.2B Private financingDetails
New companies 2 · Follow-on 0
Stages: Undisclosed 2
Henry ¥1.2B Venture debt and equityUnited Immunity ¥2.2B Private financingDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Mecka $60M Series BDynamic Creatures Undisclosed SeedDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Nous Research $90M Series BPhysical Superintelligence (PSI) $58M SeedDetails
New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Henry ¥1.2B Venture debt and equityWunderbar Inc. Undisclosed Series A extensionDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Flyle ¥1.9B Series APower Laser Technology Inc. ~¥1.2B SeedDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Vinci $250M Series BElio $21M UndisclosedDetails
Details
Details
New companies 2 · Follow-on 0
Stages: Growth 1, Series A 1
Melius $20M Series AArchive Undisclosed Growth investmentDetails
New companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
WhiteLab Genomics $26M Series BAbstract $25M UndisclosedDetails
New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Sensible Biotechnologies $47M Series AZenithon AI $10M SeedDetails
Details
New companies 1 · Follow-on 1
Stages: Series C+ 2
Savvy Wealth $100M Series CSavvy Wealth $100M Series C“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.